Lidocaine-Tchaikapharma is the company’s newest product with a marketing authorization issued by BDA

Lidocaine-Tchaikapharma 10 mg and 20 mg solution for injection is Tchaikapharma’s newest product which has obtained a Marketing Authorization issued by the Bulgarian Drug Agency.

Therapeutic indications:

  • For local anesthesia in surgery, dentistry, urology, cardiology, ophthalmology, otorhinolaryngology and other invasive instrumental investigations.
  • For the treatment of ventricular arrhythmias, including after myocardial infarction and cardiac surgery interventions.

 

ATC code: C01BB 01, N01BB 02